These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 33365081)
1. Proliferation, migration and invasion of triple negative breast cancer cells are suppressed by berbamine via the PI3K/Akt/MDM2/p53 and PI3K/Akt/mTOR signaling pathways. Liu L; Yan J; Cao Y; Yan Y; Shen X; Yu B; Tao L; Wang S Oncol Lett; 2021 Jan; 21(1):70. PubMed ID: 33365081 [TBL] [Abstract][Full Text] [Related]
2. Berbamine Inhibits Cell Proliferation and Migration and Induces Cell Death of Lung Cancer Cells via Regulating c-Maf, PI3K/Akt, and MDM2-P53 Pathways. Liu L; Xu Z; Yu B; Tao L; Cao Y Evid Based Complement Alternat Med; 2021; 2021():5517143. PubMed ID: 34306137 [TBL] [Abstract][Full Text] [Related]
3. Actin-Like Protein 8 Promotes the Progression of Triple-Negative Breast Cancer via Activating PI3K/AKT/mTOR Pathway. Fan S; Yan S; Yang Y; Shang J; Hao M Onco Targets Ther; 2021; 14():2463-2473. PubMed ID: 33883901 [TBL] [Abstract][Full Text] [Related]
4. Rhizoma Amorphophalli inhibits TNBC cell proliferation, migration, invasion and metastasis through the PI3K/Akt/mTOR pathway. Wu C; Qiu S; Liu P; Ge Y; Gao X J Ethnopharmacol; 2018 Jan; 211():89-100. PubMed ID: 28962890 [TBL] [Abstract][Full Text] [Related]
5. The Anticancer Effects of Marine Carotenoid Fucoxanthin through Phosphatidylinositol 3-Kinase (PI3K)-AKT Signaling on Triple-Negative Breast Cancer Cells. Ahmed SA; Mendonca P; Messeha SS; Oriaku ET; Soliman KFA Molecules; 2023 Dec; 29(1):. PubMed ID: 38202644 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A. Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639 [TBL] [Abstract][Full Text] [Related]
7. PIK3CA mutation confers resistance to chemotherapy in triple-negative breast cancer by inhibiting apoptosis and activating the PI3K/AKT/mTOR signaling pathway. Hu H; Zhu J; Zhong Y; Geng R; Ji Y; Guan Q; Hong C; Wei Y; Min N; Qi A; Zhang Y; Li X Ann Transl Med; 2021 Mar; 9(5):410. PubMed ID: 33842631 [TBL] [Abstract][Full Text] [Related]
8. Effects of endoplasmic reticulum stress on the autophagy, apoptosis, and chemotherapy resistance of human breast cancer cells by regulating the PI3K/AKT/mTOR signaling pathway. Zhong JT; Yu J; Wang HJ; Shi Y; Zhao TS; He BX; Qiao B; Feng ZW Tumour Biol; 2017 May; 39(5):1010428317697562. PubMed ID: 28459209 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway. Han J; Yu J; Dai Y; Li J; Guo M; Song J; Zhou X Bosn J Basic Med Sci; 2019 Feb; 19(1):52-59. PubMed ID: 29924958 [TBL] [Abstract][Full Text] [Related]
10. [Molecular mechanisms of resistance to phosphatidyl inositol 3-kinase inhibitors in triple-negative breast cancer cells]. Zhang WL; Ma WJ; Chen S; Wu XZ; Zhang HR; Zhang JH Zhonghua Zhong Liu Za Zhi; 2016 Aug; 38(8):578-88. PubMed ID: 27531477 [TBL] [Abstract][Full Text] [Related]
11. Elevated estrogen receptor β expression in triple negative breast cancer cells is associated with sensitivity to doxorubicin by inhibiting the PI3K/AKT/mTOR signaling pathway. Lei S; Fan P; Wang M; Zhang C; Jiang Y; Huang S; Fang M; He Z; Wu A Exp Ther Med; 2020 Aug; 20(2):1630-1636. PubMed ID: 32742395 [TBL] [Abstract][Full Text] [Related]
12. Tetrandrine-Induced Autophagy in MDA-MB-231 Triple-Negative Breast Cancer Cell through the Inhibition of PI3K/AKT/mTOR Signaling. Guo Y; Pei X Evid Based Complement Alternat Med; 2019; 2019():7517431. PubMed ID: 30713576 [TBL] [Abstract][Full Text] [Related]
13. Tryptophan hydroxylase 1 and 5-HT Gautam J; Banskota S; Regmi SC; Ahn S; Jeon YH; Jeong H; Kim SJ; Nam TG; Jeong BS; Kim JA Mol Cancer; 2016 Nov; 15(1):75. PubMed ID: 27871326 [TBL] [Abstract][Full Text] [Related]
14. The combined effect and mechanism of antiangiogenic drugs and PD-L1 inhibitor on cell apoptosis in triple negative breast cancer. Li J; Zhang D; Liu Z; Wang Y; Li X; Wang Z; Liang G; Yuan X; Li Y; Komorowski AL; Rozen WM; Orlandi A; Takabe K; Franceschini G; Jerusalem G; Wang X Ann Transl Med; 2023 Jan; 11(2):83. PubMed ID: 36819490 [TBL] [Abstract][Full Text] [Related]
15. Silence of α1-Antitrypsin Inhibits Migration and Proliferation of Triple Negative Breast Cancer Cells. Zhao Z; Ma J; Mao Y; Dong L; Li S; Zhang Y Med Sci Monit; 2018 Sep; 24():6851-6860. PubMed ID: 30260937 [TBL] [Abstract][Full Text] [Related]
16. Ethanol Extract of Chen X; Li S; Li D; Li M; Su Z; Lai X; Zhou C; Chen S; Li S; Yang X; Su J; Zhang Y Front Pharmacol; 2020; 11():606. PubMed ID: 32411003 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-10a suppresses breast cancer progression via PI3K/Akt/mTOR pathway. Ke K; Lou T Oncol Lett; 2017 Nov; 14(5):5994-6000. PubMed ID: 29113237 [TBL] [Abstract][Full Text] [Related]
18. UNBS5162 induces growth inhibition and apoptosis via inhibiting PI3K/AKT/mTOR pathway in triple negative breast cancer MDA-MB-231 cells. Yue X; Li M; Chen D; Xu Z; Sun S Exp Ther Med; 2018 Nov; 16(5):3921-3928. PubMed ID: 30344670 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms of Yiai Fuzheng formula in the treatment of triple-negative breast cancer based on UPLC-Q-Orbitrap-HRMS, network pharmacology, and experimental validation. Li R; Ke H; Liu P; Yang Q; Li Y; Ke L; Wang X; Wu C; Zhang Y Heliyon; 2024 Sep; 10(17):e36579. PubMed ID: 39319146 [TBL] [Abstract][Full Text] [Related]
20. Luteolin suppresses androgen receptor-positive triple-negative breast cancer cell proliferation and metastasis by epigenetic regulation of MMP9 expression via the AKT/mTOR signaling pathway. Wu HT; Lin J; Liu YE; Chen HF; Hsu KW; Lin SH; Peng KY; Lin KJ; Hsieh CC; Chen DR Phytomedicine; 2021 Jan; 81():153437. PubMed ID: 33352494 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]